Skip to Main Content

Paper Details

Incorporating progesterone receptor expression into the PREDICT breast prognostic model.
Eur J Cancer
7
2022
Breast Cancer, ER, ER-negative tumours, PR, PREDICT, breast cancer, invasive, invasive breast cancer, oestrogen, oestrogen receptor, patients, progesterone, progesterone receptor, women
Author NameAffiliation
Roger L MilneAustralia The University of Melbourne, Australia Monash University, School of Clinical Sciences at Monash Health
Graham G GilesAustralia The University of Melbourne, Australia Monash University, School of Clinical Sciences at Monash Health
Peter A FaschingUniversity of California at Los Angeles, David Geffen School of Medicine, USA Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU)
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Canada University of Toronto
Irene L AndrulisLunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Fred A. Litwin Center for Cancer Genetics, Canada University of Toronto
Hoda Anton-CulverUniversity of California Irvine, Genetic Epidemiology Research Institute
Hoda Anton-CulverUniversity of California Irvine, Genetic Epidemiology Research Institute
Christine L ClarkeUniversity of Sydney, Westmead Institute for Medical Research
Christine L ClarkeUniversity of Sydney, Westmead Institute for Medical Research
Fergus J CouchMayo Clinic
Fergus J CouchMayo Clinic
Alison M DunningUniversity of Cambridge
Douglas F EastonUniversity of Cambridge, UK University of Cambridge
Jonine D FigueroaNational Cancer Institute, National Institutes of Health, USA The University of Edinburgh, UK The University of Edinburgh
Jonine D FigueroaNational Cancer Institute, National Institutes of Health, USA The University of Edinburgh, UK The University of Edinburgh
Christopher A HaimanUniversity of Southern California, Keck School of Medicine
Christopher A HaimanUniversity of Southern California, Keck School of Medicine
Per HallKarolinska Institutet
Ming-Feng HouKaohsiung Municipal Hsiao-Kang Hospital
Esther M JohnStanford University School of Medicine, USA Stanford Cancer Institute
Vessela N KristensenOslo University Hospital and University of Oslo, Norway University of Oslo
Diether LambrechtsVIB Center for Cancer Biology, Belgium University of Leuven
Jan LubinskiPomeranian Medical University
Jan LubinskiPomeranian Medical University
Ana OsorioSpanish National Cancer Research Centre (CNIO)
Paolo RadiceFondazione IRCCS Istituto Nazionale dei Tumori (INT)
Hans-Peter SinnUniversity Hospital Heidelberg, Institute of Pathology
Carolien H M van DeurzenErasmus University Medical Center
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Montserrat Garcia-ClosasNational Cancer Institute, National Institutes of Health
Paul D P PharoahUniversity of Cambridge, UK University of Cambridge
Paul D P PharoahUniversity of Cambridge, UK University of Cambridge
  • 1 - 32

Datasets